Android app Apple app link

Icotrokinra long-term results affirm promise of targeted oral peptide with high rates of durable skin clearance and favorable safety profile in difficult-to-treat scalp and genital psoriasis

By Yahoo! Finance   |   1 month ago
Icotrokinra long-term results affirm promise of targeted oral peptide with high rates of durable skin clearance and favorable safety profile in difficult-to-treat scalp and genital psoriasis

New data from Phase 3 study shows icotrokinra's success in treating scalp and genital psoriasis with high clearance rates by Week 52. The once daily pill maintains clear skin in patients with plaque psoriasis, offering a promising treatment option.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.